anxiety/sedation/depression Flashcards

drugs targeting GABA: list the principal clinical uses and adverse effects of drugs acting on the GABAergic system and explain how pharmacokinetic differences determine clinical use

1
Q

activity of benzodiazepines and barbiturates alone on GABA-A receptor complex

A

no activity alone (allosteric action as positive allosteric modulators)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

mechanism of benzodiazepines (with GABA)

A

increase frequency of openings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

mechanism of barbiturates (with GABA)

A

increase duration of openings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

relative selectivity of barbiturates and benzodiazepines

A

barbiturates are less selective than benzodiazepines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

effect of barbiturates on excitatory transmission

A

decrease, plus other membrane effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what may barbiturates causing a decrease in excitatory transmission explain

A

induction of surgical anaesthesia, low margin of safety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

clincal use specific to barbiturates, with example

A

anaesthetics e.g. thiopentone which induces generalised anaesthesia before switching over to gaseous anaesthetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

4 clinical uses of barbiturates and benzodiazepines

A

anticonvulsants, anti-spastics, anxiolytics, sedatives/hypnotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

examples of anticonvulsant drugs

A

diazepam (benzodiazepine), clonazepam (benzodiazepine), phenobarbital (barbiturate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

example of anti-spastic drug

A

diazepam (benzodiazepine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

define anxiolytic

A

drug which removes anxiety without impairing mental or physical activity (minor tranquillisers); typically different drugs to sedatives and hypnotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

define sedative

A

drug which reduces mental and physical activity without producing loss of consciousness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

define hypnotic

A

drug which induces sleep (continuous spectrum so if reduce dose, can cause sedative effects)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

6 ideal properties of anxiolytics, sedatives and hypnotics

A

wide margin of safety, not depress respiration, produce natural sleep (hypnotics), not interact with other drugs, not produce ‘hangovers’, not produce dependence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

structure of barbiturates

A

6-membered ring structure of R1 (ethyl group), R2 (phenyl group) and X group: C(O)C(R1, R2)C(O)NC(X)N(H) molecule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

clinical uses of barbiturates

A

sedative, hypnotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

example of barbiturate causing sedation and hypnosis

A

amobarbital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what does amobarbital treat

A

severe intractable insomnia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

half-life of barbiturates

A

20-25 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

6 unwanted effects of barbiturates which mean they are not drug of 1st choice

A

low safety margins (depress respiration, overdosing lethal), alter natural sleep (decrease REM) which causes hangovers and irritability, enzyme inducers (co-administered drugs less effective), potentiate effect of other CNS depressants (e.g. alcohol), tolerance, dependence (withdrawal syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

5 features of withdrawal syndrome from barbiturates

A

insomnia, anxiety, tremor, convulsions, death

22
Q

structure of benzodiazepines

A

3-ring structure with small R1, 2, 3 and 4 groups

23
Q

structure of flumazenil meaning it works as antagonist

A

large R group so acts as antagonist as no efficacy

24
Q

where do benzodiazepines act

A

all act at GABA-A receptors, with all having similar potencies and profiles (pharmacokinetics largely determines use)

25
Q

describe administration of benzodiazepines

A

well absorbed orally, with a peak plasma concentration after 1 hour; can be given i.v. to treat status epilepticus (severe prolonged seizure activity)

26
Q

describe distrubution of benzodiazepines

A

bind plasma proteins strongly, and are highly lipid soluble so have a wide distribution

27
Q

describe metabolism of benzodiazepines

A

usually extensive metabolsim in liver

28
Q

describe excretion of benzodiazepines

A

urine as glucoronide conjugates

29
Q

duration of action of benzodiazepines, and hence 2 groups

A

vary greatly (short-acting or long-active with slow metabolism and/or active metabolites)

30
Q

example of long-acting benzodiazepine (can be metabolised to long e.g. nordiazepam (can also be produced by metabolism of chlordiazeproxide) or short-acting benzodiazepines)

A

diazepam

31
Q

example of short-acting benzodiazepine (which diazepam is metabolised to)

A

temazepam

32
Q

example of short-acting benzodiazepine (which diazepam is metabolised to nordiazepam, which is metabolised to this drug)

A

oxazepam

33
Q

what are long-acting benzodiazepines used as

A

anxiolytics (e.g. diazepam, chlordiazepoxide, nitrazepam)

34
Q

when would oxazepam (short-acting benzodiazepines) be used as anxiolytic

A

used if hepatic impairment (increase plasma half life as reduced metabolism)

35
Q

what are short-acting benzodiazepines used as

A

sedative/hypnotics (e.g. temazepam, oxazepam)

36
Q

when would nitrazepam (long-acting benzodiazepines) be used as sedative/hypnotic

A

if require daytime anxiolytic effect as longer plasma half life

37
Q

3 advantages of benzodiazepines over barbiturates

A

wide margin of safety (overdose causes prolonged sleep which is rousable e.g. using i.v. flumazenil), mild effect on REM sleep, do not induce liver enzymes (other co-administered drugs effective)

38
Q

4 unwanted effects of benzodiazepines as anxiolytic and/or hypnotic

A

sedation (if used as anxiolytic), confusion, amnesia, ataxia (impaired manual skills)

39
Q

other unwanted effects of benzodiazepines: other depressants, tolerance, dependence, co-administered drugs

A

potentiate other CNS depressants, tolerance (less than barbiturates and in tissue only), dependence (less intense withdrawal syndrome compared to barbiturates, but must withdraw slowly), increase in free plasma concentration by co-administered drugs (e.g. aspirin, heparin)

40
Q

example of another sedative/hypnotic

A

zopiclone

41
Q

where does zopiclone act

A

short-acting at benzodiazepine receptors to enhance GABA activity, with similar efficacy to benzodiazepines but are not benzodiazepines (cyclopyrolones)

42
Q

advantage and disadvantage of zopiclone as sedative/hypnotic

A

minimal hangover effects but dependency is a problem

43
Q

antidepressant drug class used as anxiolytics

A

SSRIs

44
Q

advantage and disadvantage of SSRIs as anxiolytics

A

less sedation and dependence, but have a delayed response but used for long term treatment

45
Q

2 examples of antiepileptic drugs used as anxiolytics

A

valproate, tiagabine (both enhance GABA activity in brain)

46
Q

2 examples of antipsychotic drugs used as anxiolytics (limited by side effects)

A

olanzapine, quetiapine

47
Q

how does propranolol improve physical symptoms of anxiolytics

A

tachycardia (B1), tremor (B2 on skeletal muscle fibres)

48
Q

example of 5HT-1A agonist used as anxiolytic

A

buspirone

49
Q

advantage of buspirone as anxiolytic compared to benzodiazepines

A

fewer side effects (less sedation)

50
Q

disadvantage of buspirone as anxiolytic compared to benzodiazepines

A

slower onset of action (days/weeks)